Advanced Search

Oncology & Hematology Coding Alert

What is Xofigo?

Published on Fri May 15, 2015

Xofigo is radium Ra 223 dichloride that is available as an injection. Your physician will use Xofigo to treat metastatic castration-resistant prostate cancer (mCRPC), i.e. prostate cancer that is resistant to medical or surgical treatments that lower testosterone. “In patients considered eligible to receive Xofigo, the patient would be symptomatic bone metastases and have no known visceral metastatic disease,” says [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All